ABN AMRO INVESTMENT SOLUTIONS

Position in DXCM — Dexcom Inc

CIK 2080520 PARIS CEDEX 008, I0

Position in DXCM

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$2,918,006

+$415,364 QoQ

Shares Held

43,326

+8.7% QoQ

Ownership

0.011%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#339

of 971 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ABN AMRO INVESTMENT SOLUTIONS holds $204,884,588 across 10 Medical Devices names. DXCM ranks #6 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SYK	Stryker Corp	414,338	$130,450,175
2	EW	Edwards Lifesciences Corp	425,838	$38,521,304
3	MDT	Medtronic plc	176,006	$13,768,948
4	ABT	Abbott Laboratories	111,702	$10,135,839
5	BSX	Boston Scientific Corp	120,817	$5,156,469
6	DXCM	Dexcom Inc This page	43,326	$2,918,006
7	IRTC	iRhythm Holdings, Inc.	11,500	$1,367,925
8	STE	STERIS plc	5,414	$1,140,025

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,918,006	43,326	+8.7%	Shares	Defined	2026-07-23
2026-03-31	$2,502,642	39,851	+1.1%	Shares	Other	2026-05-12
2025-12-31	$2,616,172	39,418	+12.3%	Shares	Defined	2026-02-06
2025-09-30	$2,361,811	35,099	+688.7%	Shares	Defined	2025-11-07
2025-06-30	$388,440	4,450	+11.0%	Shares	Defined	2025-08-08
2025-03-31	$273,774	4,009	-50.3%	Shares	Defined	2025-08-27
2024-12-31	$626,981	8,062	+41.0%	Shares	Defined	2025-09-04
2024-09-30	$383,200	5,716	-83.5%	Shares	Defined	2025-09-04
2024-06-30	$3,938,140	34,734	+55.0%	Shares	Defined	2025-09-04
2024-03-31	$3,108,960	22,415	+2.9%	Shares	Defined	2025-09-05
2023-12-31	$2,701,811	21,773	+0.1%	Shares	Defined	2025-09-05
2023-09-30	$2,029,554	21,753	+149.4%	Shares	Defined	2025-11-07
2023-06-30	$1,120,735	8,721	-3.3%	Shares	Defined	2025-09-05
2023-03-31	$1,048,059	9,021	—	Shares	Defined	2025-09-05
No filing history on record for this holder in this stock.